
Stock·NYSE·Consumer Cyclical
QuantumScape Corporation (QS)
- Market cap
- $2.41B
- Dividend yield
- None
- Street target
- $6.00median of 9 analysts
- 52-week range
- $3.80 $18.56
QS stock forecast today
Where QS stands today, and what CleaRank Financial AI makes of it.
QS at a glance
QuantumScape Corporation (QS): Sell, 29/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($4.95 and $6.78).
- Earnings QS beat estimates in 3 of the 6 reports in our data, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $142.7M and made no open-market purchases over the last 18 months.
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates QuantumScape Corporation (QS) Sell, with a model score of 29/100.
The trend holds it back most: the price is 42.51% below its 200-day average and 21.27% below its 50-day average, and the 50-day average is 26.97% below the 200-day. The 50-day average stands at $4.95 and the 200-day at $6.78. Over the past year the price fell 76.81%.
Only on CleaRank
Figures we compute ourselves from QS's own price, earnings and insider-filing history. Tap one to see it in context.
QS stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $3.90 is 21.3% below the 50-day simple moving average of $4.95.Price above its 200-day average ›
The price is 42.5% below the 200-day simple moving average of $6.78.50-day average above the 200-day ›
The 50-day average ($4.95) is 27.0% below the 200-day average ($6.78), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 1% of its 52-week range, between $3.80 and $18.56.
QS share price
Pick a period: each tab shows how far QS has moved over it, to the last close.
Today's trading
Where QS sits inside today's range and its 52-week range.
QS fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/1Beat estimates in most recent reports ›
QS beat the EPS estimate in 3 of the 6 reports in our data.
Key statistics
The headline figures for QS.
As of October 26, 2026, QS trades at $3.90, with a market value of $2.41B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of QS's valuation, growth and risks.
QuantumScape Corporation (QS) has no meaningful P/E, because its earnings per share over the last 12 months are negative. To put a number on it, QS carries trailing earnings of -$0.63 a share.
Its return on equity of -34.70% is below the sector median of 12.4%. Debt-to-equity comes in at 0.07.
QS reported -$0.14 a share in its most recent report, dated October 21, 2026, compared with a -$0.17 estimate. That was a better result than analysts expected. In the next session, the shares climbed 4.27%.
For the current fiscal year, analysts expect average EPS of -$0.62, and -$0.61 for the year after.
QS is a volatile stock to hold: it has moved 3.17% on an average session, and its beta against the S&P 500 is 2.84. The trend also weighs on holders until the price gets back above its moving averages. The price is 78.99% below the 52-week high of $18.56. Over the last 18 months insiders sold $142.7M of stock and bought none on the open market. Those sales are often planned in advance, so they carry less weight than purchases would.
QS against the Consumer Cyclical sector
How QS compares with the median Consumer Cyclical stock CleaRank tracks.
Return vs SPY: Since May 14, 2025, QS has lost 9.7% against a gain of 30.3% for SPY.
Performance against SPY
QS and the S&P 500 (SPY) over the same days.
Earnings reality check
Did QS beat what analysts expected, and how did the stock react?
Earnings record: QS beat the analyst estimate in 3 of the 6 reports in our data.
Market reaction: The stock fell in the first session after 1 of those 3 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 21, 2026after close | -$0.17 | -$0.14 | +17.65% | +4.27% | - |
| Jul 22, 2026after close | -$0.18 | -$0.16 | +11.11% | -12.86% | -15.50% |
| Apr 22, 2026after close | -$0.16 | -$0.16 | +0.00% | +1.37% | -6.43% |
| Oct 22, 2025after close | -$0.20 | -$0.18 | +10.00% | +7.95% | +16.64% |
| Jul 23, 2025after close | -$0.18 | -$0.20 | -11.11% | -1.56% | -31.57% |
| Apr 23, 2025after close | -$0.19 | -$0.21 | -10.53% | -0.50% | -1.76% |
As of October 26, 2026, QS has beaten the analyst EPS estimate in 3 of the 6 reports in our data and fell in the first trading session after 1 of those beats; its latest report, on October 21, 2026, came in 17.65% above the estimate and the stock moved +4.27% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
QS AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 33.5, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 33.5 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of QS
The score, the reasoning behind it, and what could move the price next.
QS is trading in a downtrend. At $3.90, the stock sits 21.27% below its 50-day average of $4.95 and 42.51% below its 200-day average of $6.78. Near the bottom of its 52-week range, the price is 2.63% above the low of $3.80, while it is 78.99% below the high of $18.56. Both averages point the same way, with the 50-day 26.97% below the 200-day.
The 14-day RSI of 33.5 is in the bearish zone, above the oversold line, and the MACD line is negative. The price is down over each of these periods: 20.57% over the past month, 24.71% over the past three months and 76.81% over the past year.
Earnings beat ›
The October 21, 2026 report beat the EPS estimate by 17.65%, and the share price rose 4.27% in the first session after it.
Source: Earnings report, October 21, 2026
Rating reaffirmed ›
Baird kept its Neutral rating on October 22, 2026.
Source: Analyst action, Baird, October 22, 2026
- The two closest levels matter most: the 20-day EMA at $4.29 sits above the price, and the 52-week low at $3.80 sits below it.
- A 14-day RSI of 33.5 falls in the bearish zone, and the MACD line is negative. Momentum is considered stretched when readings climb above 70 or drop below 30.
- The share price rose 4.27% in the first session after the October 21, 2026 report.
QS is in a downtrend, trading under both its 50-day average of $4.95 and its 200-day average of $6.78. A reclaim of the 50-day would be the first sign of repair. The closest level above the price is the 20-day EMA, at $4.29.
QS has a clear level to watch below: the 52-week low at $3.80. With the RSI in the bearish zone, momentum still leans toward that level.
Technical indicators
Momentum and trend for QS, from its daily closes.
As of October 26, 2026, with QS at $3.90, its 14-day RSI is 33.5 (showing bearish momentum without being oversold), its 50-day simple moving average is $4.95 and its 200-day is $6.78.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What QS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, QS's 1-year correlation of daily returns is +0.39 with S&P 500 (SPY), +0.43 with Nasdaq 100 (QQQ), +0.40 with Bitcoin (BTC) and +0.21 with gold (XAU).
QS price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
0 of 9 analysts rate it a buy or strong buy, 7 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $6.00 is 53.8% above the price.More buy ratings than three months ago ›
0 of 9 rate it a buy now, against 0 of 9 three months ago.
QS Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 22, 2026 | Baird | Maintains | Neutral |
| Oct 15, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Oct 12, 2026 | Evercore ISI Group | Maintains | In-Line |
| Jul 24, 2026 | TD Cowen | Maintains | Hold |
As of October 26, 2026, 9 Wall Street analysts cover QS: 0 rate it a buy or strong buy, 7 a hold and 2 a sell or strong sell. Their 12-month price targets range from $2.50 to $8.30. The median QS price target is $6.00, 53.8% above the price of $3.90.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
QS trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
QS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
QS moves about 3.2% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much QS tends to move, against the market and on its own.
QS price history and drawdowns
QS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 3.17% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 96.9%, from December 2020 to April 2025; the price is still 96.5% below that peak.Most 1-year holds ended higher ›
28% of 1-year holding periods in the last 6 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in August 2020 is now worth $3,939, against $24,649 in the S&P 500 (SPY).
QS Drawdowns & Recovery
As of October 26, 2026, QS's worst peak-to-trough fall over the last 6 years with dividends reinvested was -96.9% (December 2020 to April 2025); it is still 96.5% below that peak, and 28% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into QS in August 2020 is worth now, against the same amount in the S&P 500.
Against the market: QS trailed the S&P 500 over this period: $3,939.39 against $24,649.
A $10,000 investment in QS in August 2020 would be worth about $3,939 today with dividends reinvested, compared with about $24,649 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to QS, and which have not.
Strongest month, December: an average of +44.49%, up in 3 of 6 years.
Weakest month, August: an average of -12.08%, up in 2 of 6 years.
This month, October: has averaged -3.44%, up in 2 of 6 years. Past seasonality does not repeat on schedule.
Over the last 7 years, QS's strongest calendar month has been December (average +44.49%, up in 3 of 6 years) and its weakest August (average -12.08%, up in 2 of 6 years).
Average return for each calendar month over the last 7 years, from weekly closing prices with dividends included.
QS stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in QS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 6 years of price history, projects that a $10,000 investment in QS today could grow to about $8,180 by 2030 in the base case, with a 90th-percentile outcome near $29,466 and a 10th-percentile outcome around $2,271. Projections are statistical simulations, not guarantees.
QS Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $3.19 for QS by 2030 in the base case, from $3.90 today (0.8x over 4 years). The 10th-percentile path ends near $0.8855. These are outcomes of a Monte Carlo simulation run on QS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $1.95 | $3.71 | $7.04 | |
| 2028 | $1.43 | $3.53 | $8.73 | |
| 2029 | $1.11 | $3.35 | $10.18 | |
| 2030 | $0.8855 | $3.19 | $11.49 |
Method: a lognormal simulation of QS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
QS insider trading
What the people running the company have bought and sold.
QS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought QS shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, QS insiders reported 58 open-market sales worth $142.7M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 120.0K | $544.8K |
| Oct 5, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 59.2K | - |
| Sep 15, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 120.0K | $610.5K |
| Sep 15, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 45.0K | - |
| Aug 21, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 12.7K | $76.5K |
| Aug 21, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 12.7K | - |
| Aug 19, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 41.9K | $241.1K |
| Aug 19, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 21.5K | - |
| Jul 2, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 137.2K | $999.6K |
| Jul 2, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $71.4K |
| Jul 2, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 137.2K | - |
| Jun 22, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $77.8K |
| Jun 3, 2026 | Bradley W Buss
Director
|
Grant | 24.2K | - |
| Jun 3, 2026 | Jeneanne Michelle Hanley
Director
|
Grant | 24.2K | - |
| Jun 3, 2026 | Gena C. Lovett
Director
|
Grant | 24.2K | - |
| Jun 3, 2026 | Ross Niebergall
Director
|
Grant | 24.2K | - |
| Jun 3, 2026 | Geoffrey George Ribar
Director
|
Grant | 24.2K | - |
| Jun 3, 2026 | Dipender Saluja
Director
|
Grant | 24.2K | - |
| Jun 3, 2026 | Dennis Lynn Segers
Director
|
Grant | 24.2K | - |
| Jun 2, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 190.9K | $1.8M |
| Jun 2, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 190.9K | - |
| May 21, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 118.4K | $974.9K |
| May 21, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $79.0K |
| May 21, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 118.4K | - |
| May 20, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 184.4K | $1.4M |
| May 20, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 161.3K | - |
| May 12, 2026 | Jeffrey B Straubel
Director
|
Sell | 27.1K | $212.9K |
| May 6, 2026 | Mohit Singh
Officer
|
Sell | 50.0K | $393.7K |
| Apr 30, 2026 | Srinivasan Sivaram
Chief Executive Officer
|
Grant | 212.1K | - |
| Apr 14, 2026 | Luca Giovanni Fasoli
Chief Operating Officer
|
Grant | 801.2K | - |
| Apr 14, 2026 | Kevin Hettrich
Chief Financial Officer
|
Grant | 516.3K | - |
| Apr 14, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 658.8K | - |
| Apr 14, 2026 | Michael Owen Mccarthy III
Officer
|
Grant | 623.1K | - |
| Apr 14, 2026 | Mohit Singh
Officer
|
Grant | 623.1K | - |
| Apr 14, 2026 | Srinivasan Sivaram
Chief Executive Officer
|
Grant | 1.8M | - |
| Apr 2, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 161.3K | $996.6K |
| Apr 2, 2026 | Jeffrey Brian Straubel
Director
|
Sell | 27.1K | $167.2K |
| Apr 2, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $60.8K |
| Apr 2, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 161.3K | - |
| Mar 11, 2026 | Jeffrey Brian Straubel
Director
|
Sell | 27.1K | $188.4K |
| Mar 11, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $68.1K |
| Mar 6, 2026 | Michael Owen Mccarthy III
Officer
|
Sell | 75.0K | $510.0K |
| Mar 5, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 161.3K | $1.1M |
| Mar 5, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 161.3K | - |
| Mar 4, 2026 | Ross S. Niebergall
Director
|
Grant | 47.4K | - |
| Feb 24, 2026 | Luca Giovanni Fasoli
Chief Operating Officer
|
Grant | 26.4K | - |
| Feb 24, 2026 | Kevin Hettrich
Chief Financial Officer
|
Grant | 41.2K | - |
| Feb 24, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 42.3K | - |
| Feb 24, 2026 | Michael Owen Mccarthy III
Officer
|
Grant | 42.0K | - |
| Feb 24, 2026 | Mohit Singh
Officer
|
Grant | 42.3K | - |
| Feb 24, 2026 | Srinivasan Sivaram
Chief Executive Officer
|
Grant | 146.0K | - |
| Feb 23, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $66.2K |
| Feb 20, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 195.5K | $1.4M |
| Feb 19, 2026 | Jeffrey Brian Straubel
Director
|
Sell | 27.1K | $192.5K |
| Feb 19, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 161.3K | - |
| Jan 29, 2026 | Geoffrey George Ribar
Director
|
Grant | 36.1K | - |
| Jan 14, 2026 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $103.8K |
| Jan 5, 2026 | Timothy Holme
Chief Technology Officer
|
Sell | 211.4K | $2.4M |
| Jan 5, 2026 | Jeffrey Brian Straubel
Director
|
Sell | 27.1K | $305.7K |
| Jan 5, 2026 | Timothy Holme
Chief Technology Officer
|
Grant | 211.4K | - |
| Dec 19, 2025 | Jeffrey Brian Straubel
Director
|
Sell | 157.2K | $1.8M |
| Dec 19, 2025 | Jeffrey Brian Straubel
Director
|
Option | 130.1K | $309.2K |
| Dec 15, 2025 | Dipender Saluja
Director
|
Sell | 3.3M | $36.9M |
| Dec 15, 2025 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $108.5K |
| Dec 15, 2025 | Gena C. Lovett
Director
|
Grant | 3.4K | - |
| Dec 4, 2025 | Timothy Holme
Chief Technology Officer
|
Sell | 211.4K | $2.7M |
| Dec 4, 2025 | Timothy Holme
Chief Technology Officer
|
Grant | 211.4K | - |
| Nov 25, 2025 | Michael Owen Mccarthy III
Officer
|
Sell | 76.4K | $894.2K |
| Nov 25, 2025 | Michael Owen Mccarthy III
Officer
|
Grant | 76.4K | - |
| Nov 21, 2025 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $110.7K |
| Nov 19, 2025 | Timothy Holme
Chief Technology Officer
|
Sell | 246.7K | $3.1M |
| Nov 19, 2025 | Timothy Holme
Chief Technology Officer
|
Grant | 211.4K | - |
| Nov 7, 2025 | Michael Owen Mccarthy III
Officer
|
Sell | 20.4K | $329.4K |
| Nov 7, 2025 | Michael Owen Mccarthy III
Officer
|
Grant | 158.3K | - |
| Nov 5, 2025 | Jeffrey Brian Straubel
Director
|
Sell | 157.2K | $2.7M |
| Nov 5, 2025 | Jeffrey Brian Straubel
Director
|
Option | 130.1K | $309.2K |
| Oct 31, 2025 | Bradley W Buss
Director
|
Sell | 300.0K | $5.4M |
| Oct 31, 2025 | Bradley W Buss
Director
|
Option | 300.0K | $1.9M |
| Oct 30, 2025 | Michael Owen Mccarthy III
Officer
|
Sell | 50.0K | $789.0K |
| Oct 30, 2025 | Michael Owen Mccarthy III
Officer
|
Option | 50.0K | $118.9K |
| Oct 27, 2025 | Srinivasan Sivaram
Chief Executive Officer
|
Sell | 120.0K | $2.0M |
| Oct 24, 2025 | Friedrich Prinz
Director
|
Sell | 1.0M | $15.5M |
| Oct 24, 2025 | Bradley W Buss
Director
|
Sell | 400.0K | $6.3M |
| Oct 24, 2025 | Mohit Singh
Officer
|
Sell | 220.0K | $3.3M |
| Oct 24, 2025 | Michael Owen Mccarthy III
Officer
|
Sell | 46.3K | $706.0K |
| Oct 24, 2025 | Bradley W Buss
Director
|
Option | 400.0K | $2.5M |
| Oct 24, 2025 | Michael Owen Mccarthy III
Officer
|
Option | 25.0K | $59.4K |
| Oct 24, 2025 | Friedrich Prinz
Director
|
Grant | 980.9K | - |
| Oct 24, 2025 | Mohit Singh
Officer
|
Option | 63.0K | $149.7K |
| Oct 3, 2025 | Timothy Holme
Chief Technology Officer
|
Sell | 211.4K | $3.3M |
| Oct 3, 2025 | Timothy Holme
Chief Technology Officer
|
Grant | 153.6K | - |
| Oct 1, 2025 | Jeffrey Brian Straubel
Director
|
Sell | 157.2K | $2.2M |
| Oct 1, 2025 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $136.6K |
| Oct 1, 2025 | Jeffrey Brian Straubel
Director
|
Option | 130.1K | $309.2K |
| Sep 12, 2025 | Jeffrey Brian Straubel
Director
|
Sell | 157.2K | $1.4M |
| Sep 12, 2025 | Michael Owen Mccarthy III
Officer
|
Sell | 38.0K | $347.3K |
| Sep 12, 2025 | Kevin Hettrich
Chief Financial Officer
|
Sell | 9.8K | $90.2K |
| Sep 12, 2025 | Jeffrey Brian Straubel
Director
|
Option | 130.1K | $309.2K |
| Sep 8, 2025 | Timothy Holme
Chief Technology Officer
|
Sell | 244.5K | $1.9M |
| Sep 8, 2025 | Timothy Holme
Chief Technology Officer
|
Grant | 44.9K | - |
| Aug 19, 2025 | Mohit Singh
Officer
|
Sell | 23.6K | $204.2K |
| Jul 25, 2025 | Friedrich Prinz
Director
|
Sell | 1.0M | $11.6M |
| Jul 25, 2025 | Michael Owen Mccarthy III
Officer
|
Sell | 500.0K | $5.8M |
| Jul 25, 2025 | Michael Owen Mccarthy III
Officer
|
Option | 300.0K | $713.1K |
| Jul 25, 2025 | Friedrich Prinz
Director
|
Grant | 498.0K | - |
| Jul 16, 2025 | Srinivasan Sivaram
Chief Executive Officer
|
Grant | 450.0K | - |
| Jul 8, 2025 | Mohit Singh
Officer
|
Sell | 465.0K | $3.8M |
| Jul 8, 2025 | Mohit Singh
Officer
|
Option | 465.0K | $939.0K |
| Jul 7, 2025 | Timothy Holme
Chief Technology Officer
|
Sell | 511.8K | $3.6M |
| Jul 3, 2025 | Friedrich Prinz
Director
|
Sell | 864.7K | $6.1M |
| Jul 3, 2025 | Timothy Holme
Chief Technology Officer
|
Option | 356.0K | $261.9K |
| Jun 26, 2025 | Mohit Singh
Officer
|
Sell | 615.0K | $4.1M |
| Jun 26, 2025 | Mohit Singh
Officer
|
Option | 615.0K | $1.1M |
| Jun 4, 2025 | Bradley W Buss
Director
|
Grant | 48.2K | - |
| Jun 4, 2025 | Jeneanne Michelle Hanley
Director
|
Grant | 48.2K | - |
| Jun 4, 2025 | Gena C. Lovett
Director
|
Grant | 48.2K | - |
| Jun 4, 2025 | Dipender Saluja
Director
|
Grant | 48.2K | - |
| Jun 4, 2025 | Dennis Lynn Segers
Director
|
Grant | 48.2K | - |
| Jun 4, 2025 | Jeffrey Brian Straubel
Director
|
Grant | 48.2K | - |
| May 22, 2025 | Friedrich Prinz
Director
|
Sell | 61.5K | $242.2K |
Source: TwelveData, from SEC Form 4 filings
QS stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.
